Dr Reddy's launches prostate cancer drug in India

MUMBAI Fri Dec 7, 2012 6:32am EST

Related Topics

MUMBAI Dec 7 (Reuters) - Dr. Reddy's Laboratories Ltd , India's No. 2 drugmaker by sales, said it has launched Pamorelin, a drug to treat prostate cancer, in India.

Dr Reddy's will import and sell Pamorelin in India through an exclusive marketing deal with Switzerland-based Debiopharm Group, the Indian company said in a statement on Friday. (Reporting by Kaustubh Kulkarni; Editing by Prateek Chatterjee)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.